SHSE:605016 (China)
Â
Class A
Â¥
17.01
(-1.33%)
Dec 27
Business Description
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
ISIN : CNE1000052N4
Share Class Description:
SHSE:605016: Class ACompare
Compare
Traded in other countries / regions
605016.China IPO Date
2021-04-21Description
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.6 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.28 | |||||
| Interest Coverage | 102.46 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 12.66 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.2 | |||||
| 3-Year EBITDA Growth Rate | 8.8 | |||||
| 3-Year EPS without NRI Growth Rate | 10.4 | |||||
| 3-Year Book Growth Rate | 17.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 40.14 | |||||
| Future 3-5Y Total Revenue Growth Rate | 32.58 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.81 | |||||
| 9-Day RSI | 49.57 | |||||
| 14-Day RSI | 49.81 | |||||
| 6-1 Month Momentum % | -19.18 | |||||
| 12-1 Month Momentum % | -24.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.84 | |||||
| Quick Ratio | 2.32 | |||||
| Cash Ratio | 1.36 | |||||
| Days Inventory | 77.54 | |||||
| Days Sales Outstanding | 74.43 | |||||
| Days Payable | 100.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.7 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| Forward Dividend Yield % | 1.7 | |||||
| 5-Year Yield-on-Cost % | 1.7 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.31 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.31 | |||||
| Operating Margin % | 24.48 | |||||
| Net Margin % | 22.64 | |||||
| FCF Margin % | -6.29 | |||||
| ROE % | 15.18 | |||||
| ROA % | 12.83 | |||||
| ROIC % | 19.67 | |||||
| ROC (Joel Greenblatt) % | 27.4 | |||||
| ROCE % | 17.16 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.3 | |||||
| Forward PE Ratio | 14.96 | |||||
| PE Ratio without NRI | 23.3 | |||||
| Price-to-Owner-Earnings | 60.53 | |||||
| PS Ratio | 5.27 | |||||
| PB Ratio | 3.39 | |||||
| Price-to-Tangible-Book | 3.5 | |||||
| Price-to-Operating-Cash-Flow | 25.13 | |||||
| EV-to-EBIT | 19.42 | |||||
| EV-to-EBITDA | 19.42 | |||||
| EV-to-Revenue | 4.99 | |||||
| EV-to-FCF | -79.22 | |||||
| Price-to-Graham-Number | 1.9 | |||||
| Price-to-Net-Current-Asset-Value | 10.01 | |||||
| Price-to-Net-Cash | 53.16 | |||||
| Earnings Yield (Greenblatt) % | 5.15 | |||||
| FCF Yield % | -1.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,034.855 | ||
| EPS (TTM) (Â¥) | 0.73 | ||
| Beta | 1.12 | ||
| Volatility % | 40.58 | ||
| 14-Day RSI | 49.81 | ||
| 14-Day ATR (Â¥) | 0.639187 | ||
| 20-Day SMA (Â¥) | 16.8835 | ||
| 12-1 Month Momentum % | -24.14 | ||
| 52-Week Range (Â¥) | 14.54 - 23.961538 | ||
| Shares Outstanding (Mil) | 323.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Frequently Asked Questions
What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016)'s stock price today?
The current price of SHSE:605016 is ¥17.01. The 52 week high of SHSE:605016 is ¥23.96 and 52 week low is ¥14.54.
When is next earnings date of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016)?
The next earnings date of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) is .
Does Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) is 1.7% (As of Today), Highest Dividend Payout Ratio of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) was 0.37. The lowest was 0.11. And the median was 0.17. The  Forward Dividend Yield % of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) is 1.7%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers